Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Chris Lange | Oct 31, 2016 at 2:54 PM EDT

Ophthotech Rises on Positive Mid-Stage Results

Ophthotech Corp. (NASDAQ: OPHT) is watching its shares rise in Monday’s trading session after the company reported results from its…

Chris Lange | Oct 31, 2016 at 10:25 AM EDT

What to Expect From Pfizer Earnings

Pfizer is scheduled to release its third-quarter financial results before the markets open on Tuesday.

Chris Lange | Oct 31, 2016 at 9:05 AM EDT

Ariad Pharma Rises on FDA Decision

Shares of Ariad Pharmaceuticals saw a modest gain early Monday after the company announced a recent FDA decision.

Chris Lange | Oct 29, 2016 at 2:15 PM EDT

Genocea Biosciences Rises on Positive Herpes Trial Results

Genocea Biosciences shares saw a handy gain early Friday following the release of mid-stage results from its genital herpes treatment.

Chris Lange | Oct 28, 2016 at 10:25 AM EDT

Is This the Beginning of the End of Opexa?

Opexa Therapeutics Inc. (NASDAQ: OPXA) shares were in free fall Friday morning after the company reported results from its mid-stage…

Chris Lange | Oct 28, 2016 at 10:05 AM EDT

AbbVie Slides on Top-Line Miss

AbbVie reported mixed third-quarter financial results and a dividend hike before the markets opened on Friday.

Chris Lange | Oct 28, 2016 at 9:10 AM EDT

Amgen Sinks Despite Beating Street Estimates

Though Amgen reported better-than-expected third-quarter results on Thursday, shares sank early Friday.

Chris Lange | Oct 27, 2016 at 12:05 PM EDT

Myovant Sciences Enters the Market in IPO

Myovant Sciences entered the market near the high end of its expected price range for its initial public offering.

Jon C. Ogg | Oct 27, 2016 at 11:35 AM EDT

Is Community Health Facing an Outright Implosion?

Community Health Systems is looking and acting like it is an implosion waiting to happen. The company has projected a…

Chris Lange | Oct 27, 2016 at 10:50 AM EDT

ProQR Jumps on Positive Phase 1 Results

Shares of ProQR Therapeutics jumped early on Thursday after the company announced results from its cystic fibrosis study.

Chris Lange | Oct 26, 2016 at 3:27 PM EDT

What to Look For in Bristol-Myers Earnings

Bristol-Myers Squibb Co. (NYSE: BMY) is scheduled to release third-quarter financial results before markets open on Thursday. The consensus estimates…

Chris Lange | Oct 26, 2016 at 11:35 AM EDT

Ra Pharmaceuticals IPO Off to a Strong Start

Ra Pharmaceuticals had a very strong entrance to the market on Wednesday, with shares going out at the top of…

Chris Lange | Oct 26, 2016 at 10:45 AM EDT

Boston Scientific Remains Flat After Meeting Earnings

Boston Scientific reported its third-quarter financial results before the markets opened on Wednesday.

Chris Lange | Oct 26, 2016 at 10:05 AM EDT

Biogen Rises on Solid Earnings Beat

Biogen reported better-than-expected third-quarter financial results before the markets opened on Wednesday,

Chris Lange | Oct 26, 2016 at 7:40 AM EDT

Short Sellers Grow More Selective on Major Pharma Stocks

The October 14 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short…

1 … 187 188 189 190 191 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Ophthotech Rises on Positive Mid-Stage Results

What to Expect From Pfizer Earnings

Ariad Pharma Rises on FDA Decision

Genocea Biosciences Rises on Positive Herpes Trial Results

Is This the Beginning of the End of Opexa?

AbbVie Slides on Top-Line Miss

Amgen Sinks Despite Beating Street Estimates

Myovant Sciences Enters the Market in IPO

Is Community Health Facing an Outright Implosion?

ProQR Jumps on Positive Phase 1 Results

What to Look For in Bristol-Myers Earnings

Ra Pharmaceuticals IPO Off to a Strong Start

Boston Scientific Remains Flat After Meeting Earnings

Biogen Rises on Solid Earnings Beat

Short Sellers Grow More Selective on Major Pharma Stocks

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that's now reaching retirees' statements

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Live: Navitas Semiconductor Q1 Earnings Tonight. Can the 676% Surge Survive the Print?

Health and Healthcare Articles

All Health and Healthcare Articles

Ophthotech Rises on Positive Mid-Stage Results

What to Expect From Pfizer Earnings

Ariad Pharma Rises on FDA Decision

Genocea Biosciences Rises on Positive Herpes Trial Results

Is This the Beginning of the End of Opexa?

AbbVie Slides on Top-Line Miss

Amgen Sinks Despite Beating Street Estimates

Myovant Sciences Enters the Market in IPO

Is Community Health Facing an Outright Implosion?

ProQR Jumps on Positive Phase 1 Results

What to Look For in Bristol-Myers Earnings

Ra Pharmaceuticals IPO Off to a Strong Start

Boston Scientific Remains Flat After Meeting Earnings

Biogen Rises on Solid Earnings Beat

Short Sellers Grow More Selective on Major Pharma Stocks

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

Featured Reads

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that's now reaching retirees' statements

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check